IDEXX Laboratories to Release 2023 Third Quarter Financial Results
05 Octubre 2023 - 3:00PM
Business Wire
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet
healthcare innovation, has scheduled the release of its 2023 third
quarter results for Wednesday, November 1, 2023 before the market
opens. The Company will conduct an analyst conference call
beginning at 8:30 a.m. ET on that day.
Individuals can access a live webcast of the conference call,
transcript of prepared remarks, and the Q3 2023 Earnings Snapshot
through a link on the IDEXX website, www.idexx.com/investors. An
archived edition of the webcast will be available after 1:00 p.m.
ET on that day via the same link and will remain available for one
year.
The live call also will be accessible by telephone. To listen to
the live conference call, please dial 1-800-289-0459 or
1-773-377-9037 and reference passcode 917383.
About IDEXX Laboratories
IDEXX is a global leader in pet healthcare innovation. Our
diagnostic and software products and services create clarity in the
complex, constantly evolving world of veterinary medicine. We
support longer, fuller lives for pets by delivering insights and
solutions that help the veterinary community around the world make
confident decisions—to advance medical care, improve efficiency,
and build thriving practices. Our innovations also help ensure the
safety of milk and water across the world and maintain the health
and well-being of people and livestock. IDEXX Laboratories, Inc. is
a member of the S&P 500® Index. Headquartered in Maine, IDEXX
employs nearly 11,000 people and offers solutions and products to
customers in more than 175 countries and territories. For more
information about IDEXX, visit www.idexx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231005287398/en/
Investor Relations: investorrelations@idexx.com
IDEXX Laboratories (NASDAQ:IDXX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
IDEXX Laboratories (NASDAQ:IDXX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024